Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
OBSERVATIONAL
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male or female
* 18-55 years old
* patients with severe lipid disorders
* fasting plasma cholesterol, triglyceride or glucose, blood pressure or waist circumference/BMI out of normal range
Exclusion Criteria
18 Years
54 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lipid Clinic, The National Hospital, Oslo, Norway
UNKNOWN
Research Institute of Internal Medicine, The National Hospital, Oslo, Norway
UNKNOWN
Ullevaal University Hospital
OTHER
Norwegian Institute of Public Health
OTHER_GOV
Hormone Laboratory, Aker University Hospital, Oslo, Norway
OTHER
CIGENE, Agricultural University of Norway, Aas, Norway
OTHER
University of Oslo
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hilde I Nebb, PhD
Role: STUDY_CHAIR
Department of Nutrition, University of Oslo
Karianne Solaas, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Nutrition, University of Oslo
Monica H Carlsen
Role: PRINCIPAL_INVESTIGATOR
Department of Nutrition, University of Oslo
Leiv Ose, Dr med
Role: PRINCIPAL_INVESTIGATOR
Lipid Clinic, The National Hospital
Marit S Nenseter, PhD
Role: PRINCIPAL_INVESTIGATOR
Research Institute of Internal Medicine, The National Hospital
Kirsten Holven, PhD
Role: PRINCIPAL_INVESTIGATOR
Research Institute of Internal Medicine, The National Hospital
Bente Halvorsen, PhD
Role: PRINCIPAL_INVESTIGATOR
Research Institute of Internal Medicine, The National Hospital
Serena Tonstad, Dr med
Role: PRINCIPAL_INVESTIGATOR
Department of Preventive Medicine, Ullevål university hospital
Håkon Gjessing, PhD
Role: PRINCIPAL_INVESTIGATOR
Norwegian Institute of Public Health
Per Thorsby, Dr med
Role: PRINCIPAL_INVESTIGATOR
Hormone laboratory, Aker university hospital
Sigbjørn Lien, PhD
Role: PRINCIPAL_INVESTIGATOR
Agricultural university of Norway
Paul Berg, PhD
Role: PRINCIPAL_INVESTIGATOR
Agricultural university of Norway
Kjetil Retterstøl, Dr med
Role: PRINCIPAL_INVESTIGATOR
Lipid Clinic, The National Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutrition, University of Oslo
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
02/4746 (SHdir)
Identifier Type: -
Identifier Source: secondary_id
10163 (NSD)
Identifier Type: -
Identifier Source: secondary_id
S-03150 (REK)
Identifier Type: -
Identifier Source: org_study_id